In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
All content for GFN News is the property of GFN.TV and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
GFN.TV Interviews | STONEWALLED | The March Toward Nicotine Prohibition
GFN News
27 minutes 4 seconds
1 month ago
GFN.TV Interviews | STONEWALLED | The March Toward Nicotine Prohibition
It was perhaps inevitable that once smoking was “handled,” tobacco control would turn its fire on nicotine. From the UK’s disposable vape ban to EU pouch restrictions and the WHO’s war on nicotine, prohibition is on the march. Shot on location at GFN 2025 in Warsaw, Christopher Snowdon, Head of Lifestyle Economics at the Institute of Economic Affairs, delivers a stark assessment: public health is recycling old fears, ignoring evidence, and steering policy into prohibitionist chaos. With governments fueling black markets and pushing vapers back to smoking, Snowdon warns the war on nicotine has only just begun.
Featuring:
CHRISTOPHER SNOWDON
Head of Lifestyle Econ., Inst. of Economic Affairs
Author, columnist, public health critic
iea.org.uk
nannystateindex.org
GFN News
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
